Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance

Eur Urol. 2011 Feb;59(2):301-2. doi: 10.1016/j.eururo.2010.11.009.

Authors

Edward N Rampersaud Jr¹, Arie S Belldegrun

Affiliation

¹ Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

PMID: 21414876
DOI: 10.1016/j.eururo.2010.11.009

No abstract available

Publication types

Comment